Methylphenidate and Autism
Ranking:
Other Reading
This section provides details of other publications on this topic.
You can find more publications on this topic in our publications database.
If you know of any other publications we should list on this page please email info@informationautism.org
Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.
Related Other Reading
-
Abanilla P. K.
et al.
(2005)
The use of psychostimulants in pervasive developmental disorders.
Psychiatric Quarterly.
76(3),
Read Abstract
(New Window)
-
Aman M. G. (1996)
Stimulant drugs in the developmental disabilities revisited.
Journal of Developmental and Physical Disabilities.
8(4),
Read Abstract
(New Window)
-
Cortese S.
et al.
(2012)
Psychostimulants for ADHD-like symptoms in individuals with autism spectrum disorders.
Expert Review of Neurotherapeutics.
12(4),
Read Abstract
(New Window)
Read Full
(New Window)
-
Davis N. O., Kollins S. (2012)
Treatment for co-occurring attention deficit-hyperactivity disorder and autism spectrum disorder.
Neurotherapeutics.
9(3),
Read Abstract
(New Window)
Read Full
(New Window)
-
Mahajan R.
et al.
(2012)
Clinical practice pathways for evaluation and medication choice for attention-deficit/hyperactivity disorder symptoms in autism spectrum disorders.
Pediatrics.
130
Read Abstract
(New Window)
Read Full
(New Window)
-
Miller N. L., Findling R. L. (2007)
Is methylphenidate a safe and effective treatment for ADHD-like symptoms in children with pervasive developmental disorders?
Expert Opinion on Pharmacotherapy.
8(7),
Read Abstract
(New Window)
-
National Institute for Health and Clinical Excellence (2000)
Methylphenidate, atomoxetine and dexamfetamine for the treatment of attention deficit hyperactivity disorder in children and adolescents (including a review of guidance TA13)
London:
National Institute for Health and Clinical Excellence
Read Full
(New Window)
-
National Institute for Health and Clinical Excellence (2000)
Guidance on the use of methylphenidate (Ritalin, Equasym) for attention deficit/hyperactivity disorder (ADHD) in childhood: Information for patients.
London:
National Institute for Health and Clinical Excellence
-
Reichow B., Volkmar F. R., Bloch M. H. (2013)
Systematic review and meta-analysis of pharmacological treatment of the symptoms of attention-deficit/hyperactivity disorder in children with pervasive developmental disorders.
Journal of Autism and Developmental Disorders.
43(10),
Read Abstract
(New Window)
Read Full
(New Window)
-
Royal College of Psychiatrists (2017)
Attention-deficit hyperactivity disorder and hyperkinetic disorder: information for parents, carers and anyone working with young people
London:
Royal College of Psychiatrists
Read Full
(New Window)
-
US Food and Drug Administration (2007)
Methylphenidate.
Bethesda, MD:
US National Library of Medicine.
Read Full
(New Window)
- Updated
- 17 Jun 2022
- Last Review
- 01 Dec 2018
- Next Review
- 01 Sep 2024